Royalty Pharma Plc (RPRX) net margin is 48.3%
Royalty Pharma Plc (RPRX) net margin is 48.3% as of 2024-12-31. That figure is from Lician’s product cache for this healthcare name — not a placeholder and not copied across tickers.
Read the full RPRX research page for quote, filings, and the rest of the model. This satellite exists so “Royalty Pharma Plc net margin” can rank with the actual number, then send you to /stock/rprx.